SMAD3 and acute respiratory distress syndrome: Therefore, inhibiting Src and Smad3 might serve as a novel therapeutic target in the management of mechanically ventilated patients with ARDS exposed to hyperoxia, whose mortality has remained substantially high with the present lung-protective ventilation strategy.